Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AgenTus Therapeutics
Lexington, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
AgenTus Therapeutics was a preclinical-stage biopharmaceutical subsidiary of Agenus focused on developing adoptive cell therapies (engineered TCRs and CARs) to treat cancer, aiming for both solid tumors and hematologic malignancies. No clinical data were reported prior to its restructuring or rebranding.
- Therapeutic areas
- Oncology
- Modalities
- T cell receptor engineered T cell therapyCAR-T cell therapyCell therapy
- Industry
- Biotech
Beyond the preview
Go deeper on AgenTus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AgenTus Therapeutics.